The relationship between health-related quality of life and frequency of spells in patients with syncope

Journal of Clinical Epidemiology

Volumn 53, Issue 12, 2000, Pages 1209-1216

  Rose, M Sarah ^a   Koshman, Mary Lou ^a   Spreng, Sheila ^a   Sheldon, Robert ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Comorbidity; EuroQol; Health related quality of life (HRQL); Population norms; Symptom burden; Syncope

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; FEMALE; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; SYNCOPE; TILT TABLE TEST;

ADULT; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYNCOPE; TILT-TABLE TEST;

EID: 0034537659     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00257-2     Document Type: Article

References (29)

1. Patients with syncope admitted to intensive care units
2. Evaluation of emergency patients with transient loss of consciousness
3. Evaluation of prognostic classifications for patients with syncope
4. Impairment of physical and psychosocial function in recurrent syncope
5. Recurrent syncope as a chronic disease; preliminary validation of a disease-specific measure of functional impairment
6. Methodology of isoproterenol-tilt table testing in patients with syncope
7. Tilt table testing for assessing syncope
8. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope
9. Effect of beta blockers on the clinical outcome of patients after a positive isoproterenol-tilt table test
10. North American Vasovagal Pacemaker Study; study design and organization
11. Comparison of patients with syncope of unknown cause having negative or positive tilt table tests
12. EuroQol; a new facility for the measurement of health related quality of life
13. A new method of classification of prognostic comorbidity for longitudinal studies; Development and validation
14. Validation of a combined comorbidity index
15. Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire
16. Syncope in institutionalized elderly; the impact of multiple pathological conditions and situational stresses
17. Utility of dual chamber pacing with automatic rate-drop sensing in the prevention of recurrent neurally mediated syncope
18. Cost Effectiveness of pacemakers vs. drug therapy for the treatment of neurally mediated syncope
19. Conceptual and methodologic issues in defining quality of life; state of the art
20. Syncope associated with exercise, a manifestation of neurally mediated syncope
21. Head-up tilt test in patients with high pretest likelihood of neurally mediated syncope; an approximation to the real: sensitivity' of this testing
22. Midodrine hydrochloride in the treatment of vasovagal syncope
23. Upright tilt test; correlation between results and patient clinical features
24. Driving safety among patient with neurocardiogenic (vasovagal) syncope
25. Response to head-up tilt testing in patients with situational syncope
26. Diagnostic utility of mechanical, pharmacological and orthostatic stimulation of the carotid sinus in patients with unexplained syncope